Fenwick & West represented Morphic Holdings, Inc. in the transaction, and Kirkland & Ellis represented Eli Lilly and Company. Eli Lilly and Company (NYSE: LLY) announced...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis and Morrison Foerster advised Alpine Investors on the transaction. Alpine Investors (“Alpine”) announced it has closed a $3.4 billion single-asset continuation fund transaction to continue...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis LLP advised Bristol Myers Squibb, while Skadden, Arps, Slate, Meagher & Flom LLP advised Mirat on the deal. Bristol Myers Squibb (NYSE: BMY)...
You must be a Standard 1 Year member to access this content.
Paul, Weiss, Rifkind, Wharton & Garrison is advising Kohlberg; and Kirkland & Ellis is advising private equity firm TJC and its affiliate company Worldwide Clinical Trials...
You must be a Standard 1 Year member to access this content.
